InvestorsHub Logo
Followers 0
Posts 64
Boards Moderated 0
Alias Born 06/11/2013

Re: None

Thursday, 03/20/2014 9:45:43 PM

Thursday, March 20, 2014 9:45:43 PM

Post# of 48316
Question for Zoriden. I found it from Yahoo message board "ASGCT 17th Annual Meeting May 19th to 24th, Richard Heller, PhD Non-Viral Gene Transfer of pIL-12 for the Treatment of Melanoma: Results from Phase I and II Clinical Trials". I assume this is the results from ONCS' Phase I and II trials on melanoma. Since ONCS also submitted an abstract to ASCO, is it logical to assume that the ASCO abstract is related to data on MCC (not melanoma)? Thanks in advance for your comment.